We are pioneering the next frontier of drug delivery. we aim to transform maternal-fetal medicine and deliver safer, more precise therapies for women’s health and beyond.
We envision a future where "Exosomes—nature’s own delivery vehicles" are engineered to target diseases with unmatched precision. Our goal is to eliminate preventable pregnancy complications, accelerate new drug discovery, and extend the promise of exosome-based therapeutics into broader systemic and neurological disorders.
KaRMa Exotechnologies is pioneering a reproductive tissue–targeted drug delivery approach by engineering exosomes to carry anti-inflammatory cytokines and drug transporter proteins.
Dr.Ananth kumar Kammala M.Pharm, PhD.,
Co-Founder and CEO